Prescribed-drug utilization and polypharmacy in a general population in Greece: Association with sociodemographic, health needs, health-services utilization, and lifestyle factors

European Journal of Clinical Pharmacology

Volumn 67, Issue 2, 2011, Pages 185-192

  Pappa, E ^a   Kontodimopoulos, N ^a   Papadopoulos, A A ^a,b   Tountas, Y ^a,c   Niakas, D ^a  

^a HELLENIC OPEN UNIVERSITY   (Greece)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Drug use; General population; Greece; Health needs; Polypharmacy; Sociodemographic characteristics

Indexed keywords

ADULT; AGED; AGING; ARTICLE; COMORBIDITY; CROSS-SECTIONAL STUDY; DRUG USE; DRUG UTILIZATION; EDUCATIONAL STATUS; FEMALE; GREECE; HEALTH CARE NEED; HEALTH CARE UTILIZATION; HEALTH STATUS; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; OBESITY; POLYPHARMACY; PRESCRIPTION; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; SOCIAL ASPECT;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; FEMALE; GREECE; HEALTH SERVICES; HEALTH SERVICES NEEDS AND DEMAND; HEALTH SURVEYS; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; POLYPHARMACY; PRESCRIPTION DRUGS; SEX FACTORS; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 79151477604     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-010-0940-0     Document Type: Article

References (35)

1. AE Eggen 1994 Pattern of drug use in a general population-prevalence and predicting factors: the Tomso study Int J Epidemiol 23 1262 1272 10.1093/ije/23.6.1269 1:STN:280:DyaK2M3jvVSrtw%3D%3D 10.1093/ije/23.6.1262 7721530
2. C Del Rio C Prada J Alvarez 1997 The use of mediation by the Spanish population Pharmacoepidemiol Drug Saf 6 41 48 10.1002/pds.250 10.1002/(SICI)1099-1557(199701)6:1<41:AID-PDS250>3.0.CO;2-6 15073804
3. AE Eggen 1997 Patterns of medicine use in a general population (0-80). The influence of age, gender, diseases and place of residence on drug use in Norway Pharmacoepidemiol Drug Saf 6 179 187 10.1002/pds.258 1:STN:280: DC%2BD2c7nvV2qsw%3D%3D 10.1002/(SICI)1099-1557(199705)6:3<179:AID- PDS258>3.0.CO;2-P 15073786
4. M Simoni M Pedreschi S Baldacci, et al. 2000 The PO River Delta epidemiological study: use of medicines in a general population sample of north Italy Pharmacoepidemiol Drug Saf 9 319 326 10.1002/pds.505 1:STN:280: DC%2BD1cjmtVehtQ%3D%3D 10.1002/1099-1557(200007/08)9:4<319:AID-PDS505>3.0. CO;2-6 19025835
5. E Fernandez-Liz P Modamio A Catalan, et al. 2007 Identifying how age and gender influence prescription drug use in a primary health care environment in Catalonia Spain Br J Clin Epidemiol 65 407 417
6. J Sanfelix V Palop I Pareiro, et al. 2008 Gender influence in the quantity of drugs used in primary care Gas Sanit 22 11 19 10.1157/13115104
7. A Bardel MA Wallander K Svardsudd 2000 Reported current use of prescription drugs and some of its determinants among 35 to 65 years old women in mid-Sweden: a population-based study J Clin Epidemiol 53 637 643 10.1016/S0895-4356(99)00228-0 1:STN:280:DC%2BD3czktFyluw%3D%3D 10.1016/S0895-4356(99)00228-0 10880784
8. K Furu B Straume DS Thelle 1997 Legal drug use in a general population: Association with gender, morbidity, health care utilization and lifestyle characteristics J Clin Epidemiol 50 341 349 10.1016/S0895-4356(99)00362-9 1:STN:280:DyaK2s3ks1KktA%3D%3D 10.1016/S0895-4356(96)00362-9 9120535
9. M Bekke S Hunskaar J Straand 2006 Self-reported drug utilization, health and lifestyle factors among 70-74 year old community dwelling individuals in Western Norway. The Hordaland Health Study (HUSK) BMC Public Health 6 121 10.1186/1471-2458-6-12 10.1186/1471-2458-6-121
10. G Ringbach Weitoft M Rosen O Ericsson R Ljung 2008 Education and drug use in Sweden-a nationwide register-based study Pharmacoepidemiol Drug Saf 17 1020 1028 10.1002/pds.1635 10.1002/pds.1635
11. M Nielsen EH Hansen N Rasmussen 2003 Prescription and non-prescription medicine use in Denmark: association with socioeconomic position Eur J Clin Pharmacol 59 677 684 10.1007/s00228-003-0678-z 14523592
12. G Fillenbaum R Horner J Hanlon, et al. 1996 Factors predicting change in prescription and non-prescription drug use in a community residing black and white elderly population J Clin Epidemiol 49 587 593 10.1016/S0895-4356(95) 00563-3 1:STN:280:DyaK283ktVGjsQ%3D%3D 10.1016/0895-4356(95)00563-3 8636733
13. K Henricson P Stenberg G Rametsteiner, et al. 1998 Socioeconomic factors, morbidity and drug utilization-an ecological study Pharmacoepidemiol Drug Saf 7 261 267 10.1002/pds.364 1:STN:280:DC%2BD2c7nvFSgtQ%3D%3D 10.1002/(SICI)1099- 1557(199807/08)7:4<261:AID-PDS364>3.0.CO;2-X 15073988
14. J Gundgaard 2005 Income related inequality in prescription drugs in Denmark Pharmacoepidemiol Drug Saf 14 307 317 10.1002/pds.1039 10.1002/pds.1039 15508133
15. L Bjerrum J Sogaard J Hallas J Kragstrup 1998 Polypharmacy: correlation with sex, age and drug regimen Eur J Clin Pharmacol 54 197 202 1:STN:280:DyaK1czksV2rtg%3D%3D 10.1007/s002280050445 9681659
16. HF Thomas PM Sweetnam B Janchawee DK Luscombe 1999 Polypharmacy among older men in South Wales Eur J Clin Pharmacol 55 411 415 1:STN:280: DyaK1MzotleqtA%3D%3D 10.1007/s002280050649 10456493
17. SI Haider K Johnell M Thorslund J Fastbom 2008 Analysis of the association between polypharmacy and socioeconomic position among elderly aged>or =77 years in Sweden Clin Ther 30 419 427 10.1016/j.clinthera.2008.02. 010 18343279
18. SI Haider K Johnell GR Weitoft, et al. 2009 The influence of educational level on polypharmacy and inappropriate drug use: a register-based study of more than 600.000 older people J Am Geriatr Soc 57 62 69 10.1111/j.1532-5415.2008. 02040.x 19054196
19. U Junius-Walker G Theile E Hummers-Pradier 2006 Prevalence and predictors of polypharmacy among older primary care patients in Germany Fam Pract 24 14 19 10.1093/fampra/cml067 17164234
20. P Little M Dorward G Warner, et al. 2004 Importance of patients' pressure and perceived pressure and perceived medical need for investigations, referral, and prescribing in primary care: nested observational study Br Med J 328 444 447 10.1136/bmj.38013.644086.7C
21. LJ Veehof RE Stewart B Meyboom-de Jong FM Haaijer-Ruskamp 1999 Adverse drug reactions and polypharmacy in the elderly in general population Eur J Clin Pharmacol 55 533 536 1:CAS:528:DyaK1MXls1Cqt7c%3D 10.1007/s002280050669 10501824
22. A Alexopoulou SP Dourakis D Mantzoukis, et al. 2008 Adverse drug reactions as a cause of hospital admissions: a 6-months experience in a single center in Greece Eur J Intern Med 19 505 510 10.1016/j.ejim.2007.06.030 19013378
23. P Olivier L Bertrand M Tubery, et al. 2009 Hospitalizations because of adverse drug reactions in elderly patients admitted through the emergency department: a prospective survey Drugs Aging 26 475 482 10.2165/00002512- 200926060-00004 19591522
24. LJG Veehof RE Stewart FM Haaijer-Ruskamp B Meyboom-de Jong 2000 The development of polypharmacy. A longitudinal study Fam Pract 17 261 267 1:STN:280:DC%2BD3czpsFKksg%3D%3D 10.1093/fampra/17.3.261 10846147
25. J Jyrrka H Enlund MJ Korhonen, et al. 2009 Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the Kuopio 75+ study: a cross-sectional analysis Drugs Aging 26 493 503 10.2165/00002512-200926060-00006
26. N Antonakis I Xylouri M Alexandrakis, et al. 2005 Seeking prescribing patterns in rural Crete: a pharmacoepidemiological study from a primary care area Rural Remote Health 6 488
27. L Tzimis A Kafatos 1998 Drug utilization and health behaviours among indigent elderly patients in Crete, Greece Pharmacoepidemiol Drug Saf 8 105 114 10.1002/pds.398 10.1002/(SICI)1099-1557(199903/04)8:2<105:AID-PDS398>3.0. CO;2-X
28. OECD Health Data 2009-Frequently Requested Data. http://www.oecd.org/ document/16/0,3343,em-2649-34631-2085200-1-1-1-37407,00.html (accessed 2 February 2010)
29. J Yfantopoulos 2008 Pharmaceutical pricing and reimbursement reforms in Greece Eur J Health Econ 9 87 97 10.1007/s10198-007-0061-6 17619920
30. N Kontodimopoulos E Pappa D Niakas Y Tountas 2007 Validity of SF-12 summary scores in a Greek general population Health Qual Life Outcome 5 55 10.1186/1477-7525-5-55
31. C Pitsavos DB Panagiotakos C Chrysohoou C Stefanadis 2003 Epidemiology of cardiovascular risk factors in Greece: aims, design and baseline characteristics of the ATTICA study BMC Public Health 3 32 10.1186/1471-2458-3- 32 14567760
32. E Pappa N Kontodimopoulos A Papadopoulos D Niakas 2009 Assessing the socioeconomic and demographic impact on health related quality of life: evidence from Greece Int J Public Health 54 241 249 10.1007/s00038-009-8057-x 19424661
33. J Rosholm K Christensen 1997 Relationship between drug use and self-reported health in elderly Danes Eur J Clin Pharmacol 53 179 183 1:STN:280:DyaK1c7js1Gjtw%3D%3D 10.1007/s002280050359 9476028
34. A Bertoldi A Barros A Wagner, et al. 2008 A descriptive review of the methodologies used in household surveys on medicine utilization BMC Health Serv Res 8 222 10.1186/1472-6963-8-222 18976465
35. PA Van den Brandt H Petri E Dorant RA Goldbohm S van de Crommert 1991 Comparison of questionnaire information and pharmacy data on drug use Pharm Weekbl Sci 13 91 96 1870949